Emend Capsule
Product Images NDC 0006-0464

23 FDA label images from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Emend (NDC 0006-0464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Emend 01)

Figure (Emend 01)
An instructional diagram for EMEND capsules showing included components: a mixing cup, 5 mL and 1 mL oral dosing dispensers, a pouch of EMEND, a cap, instructions for use, and a package insert. The illustration helps guide proper preparation and administration of the oral dosage form.*
FDA Label Image

Figure (Emend 02)

Figure (Emend 02)
An instructional line drawing illustrating the act of filling a capsule container with water from a faucet, showing a hand holding the container under running water in a sink.*
FDA Label Image

Figure (Emend 03)

Figure (Emend 03)
Instructional illustration demonstrating how to fill a syringe from a medication vial. The syringe is shown with a close-up of the volume marking indicating approximately 4.6 mL drawn from the vial.*
FDA Label Image

Figure (Emend 04)

Figure (Emend 04)
Illustration showing a hand pouring liquid capsules down a drain, with drops falling from the capsules into the sink drain below.*
FDA Label Image

Figure (Emend 05)

Figure (Emend 05)
An instructional illustration showing a person holding a container with one hand and using the other hand to press down a syringe plunger inside the container, with an arrow indicating the downward motion of the plunger.*
FDA Label Image

Figure (Emend 06)

Figure (Emend 06)
An instructional illustration demonstrating how to open a packet by tearing at a notch and then pouring the contents into a measuring cup or container, shown by a pair of hands holding the packet and the container beneath it.*
FDA Label Image

Figure (Emend 07)

Figure (Emend 07)
An instructional diagram showing hand movements to open a child-resistant container. The left side illustrates rotating the cap about 20 times while pressing down, and the right side shows shaking the container up and down about 5 times.*
FDA Label Image

Figure (Emend 08)

Figure (Emend 08)
An instructional diagram showing a person closely inspecting a small pill bottle, holding it at eye level. The person is facing the bottle to read the label or contents clearly, demonstrating proper viewing technique for the medication container.*
FDA Label Image

Figure (Emend 09)

Figure (Emend 09)
Illustration showing two types of liquid dispensers: a 1 mL dispenser on the left and a 5 mL dispenser on the right. The right side of the image demonstrates a hand adjusting or using the 5 mL dispenser, indicating how to measure or dispense liquid doses.*
FDA Label Image

Figure (Emend 10)

Figure (Emend 10)
An illustration showing a syringe inserted into a vial stopper, indicating medication extraction, alongside a thermometer depicting temperature measurement. This instructional image is likely related to drug preparation or storage guidelines.*
FDA Label Image

Chemical Structure (Emend 11)

Chemical Structure (Emend 11)
Chemical structure of aprepitant, the active ingredient in EMEND. The structure displays rings and functional groups characteristic of aprepitant, including fluorinated aromatic rings and heterocyclic components.*
FDA Label Image

Figure 1 (Emend 12)

Figure 1 (Emend 12)
This figure presents two Kaplan-Meier curves comparing the percentage of patients over time (in hours) during two separate studies. Each graph contrasts the EMEND regimen with standard therapy, showing patient outcomes measured across approximately 120 hours.*
FDA Label Image

Figure 2 (Emend 13)

Figure 2 (Emend 13)
Two bar graphs comparing the percentage of patients receiving EMEND regimen versus standard therapy across chemotherapy cycles 2 through 6 in two separate studies. The y-axis represents percent of patients, while the x-axis shows the chemotherapy cycles. Below each graph, patient counts for both regimens are listed at each cycle.*
FDA Label Image

Warning (Emend 14)

FDA Label Image

Figure (Emend 15)

Figure (Emend 15)
An instructional illustration of an oral dosing dispenser syringe showing parts labeled as cap, tip, and plunger. The device is used for administering precise doses of oral medication.*
FDA Label Image

Figure (Emend 16)

Figure (Emend 16)
An instructional illustration depicting a syringe inserted into a vial cap for medication withdrawal and a thermometer showing temperature measurement.*
FDA Label Image

Figure (Emend 17)

Figure (Emend 17)
An instructional illustration showing a child being administered oral medication from a syringe, with one hand holding the child's mouth open and the other hand using the syringe to deliver the dose inside the mouth.*
FDA Label Image

Figure (Emend 18)

Figure (Emend 18)
An instructional illustration showing a hand holding a syringe above a waste container, demonstrating the proper disposal of a syringe and its needle cap into a safe receptacle.*
FDA Label Image

Principal Display Panel (80 mg Capsule Dose Pack)

Principal Display Panel (80 mg Capsule Dose Pack)
EMEND (aprepitant) 80 mg capsules in a BiPack containing 2 capsules for oral use, labeled for adults and pediatric patients 12 years and older. The packaging includes dosage instructions, safety warnings, and manufacturer information from Merck Sharp & Dohme LLC, with a pull-out strip and barcode. The capsules are illustrated on the label.*
FDA Label Image

Principal Display Panel (125 mg Capsule Carton)

Principal Display Panel (125 mg Capsule Carton)
EMEND 125 mg oral capsules packaging label for aprepitant by Merck Sharp & Dohme LLC. The label indicates 6 capsules per package, meant for adults and pediatric patients 12 years and older. Storage instructions specify 20-25°C controlled room temperature. The package is a bulk container, not child-resistant, and not intended for dispensing.*
FDA Label Image

Principal Display Panel (3 Capsule Kit Carton)

Principal Display Panel (3 Capsule Kit Carton)
EMEND TriPack packaging label for oral capsules containing aprepitant. It includes one 125 mg capsule and two 80 mg capsules, designed for adults and pediatric patients 12 years and older. The label shows capsule images, dosage information, and is labeled by Merck Sharp & Dohme LLC. The pack holds three capsules total.*
FDA Label Image

Principal Display Panel (40 mg Capsule Carton)

Principal Display Panel (40 mg Capsule Carton)
Packaging label for EMEND 40 mg capsules containing aprepitant by Merck Sharp & Dohme LLC. The label states each capsule contains 40 mg of aprepitant, is for Rx only, not child resistant, and includes storage instructions at 20-25°C. The label features the NDC 0006-0464-10 and shows one capsule per package.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Packaging label for EMEND 125 mg for oral suspension single-dose kit. The label is primarily dark blue with white text and a green 125 mg strength indicator. It includes usage instructions, storage conditions, manufacturer details (Merck Sharp & Dohme Corp.), and dispensing information. The label specifies that the kit contains one pouch, one mixing cup, and two oral dispensers with one capsule each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.